Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLeukemiaTeam Member asked a question 💭
Australia
April 8
 · 
Reactions
MyLeukemiaTeam

What are the treatment options for CMML-1 with systemic mastocytosis?

When CMML occurs alongside systemic mastocytosis, treatment approaches need to address both conditions. Here are the main options:

Stem Cell Transplant
This is the only potential cure for CMML. It involves high-dose chemotherapy followed by an infusion Show Full Answer

What are the treatment options for CMML-1 with systemic mastocytosis?

When CMML occurs alongside systemic mastocytosis, treatment approaches need to address both conditions. Here are the main options:

Stem Cell Transplant
This is the only potential cure for CMML. It involves high-dose chemotherapy followed by an infusion of donor stem cells. However, it's typically only considered for younger people in good health with more advanced disease and a matched donor available.

Chemotherapy Options
Several chemotherapy drugs may help normalize blood cell counts and reduce symptoms:
* Vidaza (azacitidine)
* Dacogen (decitabine)
* Inqovi (decitabine and cedazuridine)
* Hydrea (hydroxyurea)
* Cytosar-U (cytarabine)

Targeted Therapy for Mastocytosis
Rydapt (midostaurin) is approved specifically for mast cell leukemia and may help with the mastocytosis component. Other targeted therapies like Ayvakit (avapritinib) are being studied for advanced systemic mastocytosis.

Supportive Care
Blood transfusions, platelet transfusions, and growth factors can help manage low blood counts and improve quality of life.

Your doctor will consider your overall health, symptoms, and how quickly the disease is progressing when recommending a treatment plan. Because this combination is rare, clinical trials might offer access to newer treatment options.

April 8

Related Questions

View All
A MyLeukemiaTeam Member asked a question 💭
Australia

A MyLeukemiaTeam Member asked a question 💭
Australia

A MyLeukemiaTeam Member asked a question 💭
Australia